Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Drugpatentwatch crizotinib?
Sun pharma bortezomib?
Antiox mebendazole price?
What is dabrafenib mesylate msn patent issue?
When will a generic version of xiaflex be available?

Ingredients in eliquis?

See the DrugPatentWatch profile for eliquis

What’s in Eliquis (apixaban) besides the active drug?

Eliquis contains apixaban as the active ingredient. The tablet also includes inactive ingredients (excipients) that help form the pill and control how the drug is released and absorbed. The exact inactive ingredient list depends on the tablet strength (2.5 mg vs 5 mg) and formulation.

Which ingredients are in Eliquis tablets by strength (2.5 mg vs 5 mg)?

To tell you the precise full ingredient list, I need the tablet strength and formulation you have (for example, “Eliquis 5 mg film-coated tablets” or “Eliquis 2.5 mg film-coated tablets”). Different strengths can have different excipients.

Are there any common inactive ingredients patients often need to know about?

Many anticoagulant tablets include excipients such as film-formers/binders and processing aids, and they may contain common components like microcrystalline cellulose and other tablet-formulation materials. If you’re asking because of an allergy or sensitivity, the specific inactive ingredient list for your strength matters most.

If you’re checking for allergies, what should you look for on the label?

Check the “Inactive ingredients” section in the specific package insert for your Eliquis strength, then compare it with your known allergies. If you share the strength on your bottle (2.5 mg or 5 mg) and whether it’s tablets (not oral suspension or another product), I can help you interpret the exact ingredient list for that specific product.

Can you share the strength so I can give the exact ingredient list?

Reply with the Eliquis strength on your prescription label (2.5 mg or 5 mg) and, if shown, whether it says “film-coated tablets.” Then I’ll provide the specific ingredients for that exact version.

Sources: none provided.



Other Questions About Eliquis :

is eliquis generic Eliquis 2 5mg? Wann lauft patent eliquis aus? Average cost of eliquis? Wann lauft eliquis patent in deutschland aus? Price eliquis? Eliquis apixaban 5 mg price?

AI-Drug Label Prescribing Information Alignment Report

95
95%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The AI claim is directly supported by the FDA label language in Warnings and Precautions sections 5.1 and 5.3, including both the thrombotic risk with premature discontinuation and the hematoma/long-term or permanent paralysis risk with neuraxial anesthesia or spinal/epidural puncture.

Category Scores

Warnings
100
Excellent

Accurate Statements

Premature discontinuation of ELIQUIS increases risk of thrombotic events.
5.1 Increased Risk of Thrombotic Events after Premature Discontinuation: “Premature discontinuation of any oral anticoagulant, including ELIQUIS… increases the risk of thrombotic events.”
Premature discontinuation can result in stroke during transition to warfarin (as part of the label warning context).
5.1: “An increased rate of stroke was observed during the transition from ELIQUIS to warfarin…”
Neuraxial anesthesia/spinal/epidural puncture poses risk of spinal/epidural hematoma.
5.3 Spinal/Epidural Anesthesia or Puncture: “patients… are at risk of developing an epidural or spinal hematoma…”
Spinal/epidural hematoma can result in long-term or permanent paralysis.
5.3: “…which can result in long-term or permanent paralysis.”

Unsupported Statements

Contradictions

Important Omissions

Label-specific management details for neuraxial procedures (e.g., catheter removal timing and next dose timing; frequent neurological monitoring; emergent diagnosis/treatment) were not included in the claim.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The statements made are consistent with labeled warnings; however, the claim does not include procedural timing/monitoring specifics that are part of the label guidance.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Omission of label procedural timing/monitoring specifics for neuraxial anesthesia/puncture.

Suggested Improvement
If expanding beyond the warning summary, include the label’s specific catheter/dose timing and neurological monitoring guidance from 5.3.

Drug Brand Mention Assessment

Branding Score
41
Visibility
48
Mentioned
Ranking
#1
Sentiment
45
Recommendation Status
mentioned only
Brand Perception
Best Known For

Eliquis contains apixaban as the active ingredient

Core Claims
  • Eliquis contains apixaban as the active ingredient.
  • The tablet includes inactive ingredients (excipients).
  • The exact inactive ingredient list depends on tablet strength (2.5 mg vs 5 mg) and formulation.
Differentiators
  • Inactive ingredient list depends on tablet strength and formulation.
  • Exact ingredient list depends on whether it is Eliquis 2.5 mg vs 5 mg film-coated tablets.
Pricing Perception: Not Mentioned